Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 vaccination: Prioritization of at risk groups.
Lundon DJ, Khusid JA, Tsao CK, Patel V, Kyprianou N, Tewari A, Wiklund P. Lundon DJ, et al. Urol Oncol. 2021 Jul;39(7):375-378. doi: 10.1016/j.urolonc.2021.03.021. Epub 2021 Apr 8. Urol Oncol. 2021. PMID: 36861731 Free PMC article. No abstract available.
Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
Kaushal JB, Raut P, Muniyan S, Siddiqui JA, Alsafwani ZW, Seshacharyulu P, Nair SS, Tewari AK, Batra SK. Kaushal JB, et al. Among authors: tewari ak. Cancer Metastasis Rev. 2024 Dec;43(4):1233-1255. doi: 10.1007/s10555-024-10193-8. Epub 2024 Jun 20. Cancer Metastasis Rev. 2024. PMID: 38902476 Review.
A Novel Artificial Intelligence-powered Tool for Precise Risk Stratification of Prostate Cancer Progression in Patients with Clinical Intermediate Risk.
Nair SS, Muhammad H, Jain P, Xie C, Pavlova I, Brody R, Huang W, Nakadar M, Zhang X, Basu H, Wilding G, Roy R, Chakravarty D, Tewari AK. Nair SS, et al. Among authors: tewari ak. Eur Urol. 2024 Sep 3:S0302-2838(24)02496-5. doi: 10.1016/j.eururo.2024.07.013. Online ahead of print. Eur Urol. 2024. PMID: 39232981 No abstract available.
Novel signatures of prostate cancer progression and therapeutic resistance.
Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N. Wang J, et al. Among authors: tewari ak. Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1195-1206. doi: 10.1080/14728222.2023.2293757. Epub 2023 Dec 30. Expert Opin Ther Targets. 2023. PMID: 38108262 Review.
289 results